Temporal Changes in Linezolid Minimum Inhibitory Concentration Values in Vancomycin-resistant Enterococci and Methicillin-resistant Staphylococcus aureus Strains

Temporal Changes in Linezolid Minimum Inhibitory Concentration Values in Vancomycin-resistant Enterococci and Methicillin-resistant Staphylococcus aureus Strains

Introduction: Vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) infections are among the most common Gram-positive nosocomial infections. These isolates are resistant to most antibiotics, limiting the antibiotic options that can be used in treatment and ca...

Full description

Bibliographic Details
Main Authors:	Serpil GENÇ, Fatma Zehra DUYMAZ, Devrim DÜNDAR
Format:	Article
Language:	Turkish
Published:	Galenos Yayinevi 2019-12-01
Series:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:	epidemiology glycopeptides
Online Access:	http://mjima.org/text.php?&id=158

Similar Items

Emergence of vancomycin-resistant enterococci in South Africa: Implications for public health
by: Frank E. Tatsing Foka, et al.
Published: (2018-09-01)

In-vitro Susceptibility of Linezolid and Teicoplanin in Methicillin-resistant Staphylococcus aureus by E-test
by: Thammina Meher Srisai Sudhavani, et al.
Published: (2023-01-01)

Involving Ornithologists in the Surveillance of Vancomycin-Resistant Enterococci
by: M. Sellin, et al.
Published: (2000-02-01)

The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study
by: Cornelius Remschmidt, et al.
Published: (2017-09-01)

Prevalence of methicillin-resistant staphylococci isolated from different biological samples at Policlinico Umberto I of Rome: correlation with vancomycin susceptibility
by: Maria Teresa Mascellino, et al.
Published: (2011-03-01)

Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model
by: Sinan Mermer, et al.
Published: (2020-09-01)

Emergence of linezolid resistance in clinical isolates of vancomycin-resistant enterococci
by: Sakshee Gupta
Published: (2016-01-01)

Linezolid and Vancomycin Resistant Enterococci: A Therapeutic Problem
by: Garima Yadav, et al.
Published: (2017-08-01)

Detection of Macrolide, Lincosamide and Streptogramin Resistance among Methicillin Resistant Staphylococcus aureus (MRSA) in Mumbai
by: Arunagiri Subramanian, et al.
Published: (2015-01-01)

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
by: Alexandra G. Mills, et al.
Published: (2023-01-01)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
by: Ye Tian, et al.
Published: (2018-01-01)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
by: Mary Joyce Wingler, et al.
Published: (2021-10-01)

Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity
by: Hung-Jen Tang, et al.
Published: (2017-05-01)

Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States
by: Kurt B. Stevenson, et al.
Published: (2005-06-01)

Evaluation of Vancomycin Minimum Inhibitory Concentration in the clinical isolates of Methicillin Resistant Staphylococcus aureus (MRSA)
by: Anitha T.K., et al.
Published: (2019-09-01)

Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete
by: Andy Hesketh, et al.
Published: (2021-02-01)

COMPARISON OF IN-VITRO EFFICACY OF VANCOMYCIN, LINEZOLID AND DAPTOMYCIN AGAINST METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
by: Maria Mushtaq Gill, et al.
Published: (2019-10-01)

Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus
by: Hideo Kato, et al.
Published: (2021-03-01)

Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
by: Tsai CY, et al.
Published: (2018-08-01)

Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis
by: Tsai CY, et al.
Published: (2018-10-01)

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
by: Ahu Kara, et al.
Published: (2015-01-01)

Is there an association between colonisation of vancomycin resistant Enterococci, methicillin resistant Staphylococcus Aureus, or Clostridiodes Difficile and mortality in sepsis?
by: Matthew JG. Sigakis, et al.
Published: (2024-12-01)

Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US.
by: Natalia Blanco, et al.
Published: (2017-01-01)

In Vitro Activity of Vancomycin and Teicoplanin Against Coagulase Negative Staphylococci
by: Vishal Sharma, et al.
Published: (2011-05-01)

Minimum inhibitory concentration values and problematic disk break points of tigecycline against vancomycin and/or high-level aminoglycoside-resistant enterococci
by: Latife İşeri, et al.
Published: (2016-06-01)

Evaluation of the Negative Predictive Value of Methicillin-Resistant Staphylococcus aureus Nasal Swab Screening in the Medical Intensive Care Units and Its Effect on Antibiotic Duration
by: Tai CH, et al.
Published: (2022-03-01)

Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range
by: Phillips CJ, et al.
Published: (2016-05-01)

In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus
by: Nagalakshmi Narasimhaswamy, et al.
Published: (2017-11-01)

Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - comparison of pharmacology and clinical efficacy
by: Pletz Mathias W, et al.
Published: (2010-11-01)

In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
by: Weifeng Yang, et al.
Published: (2018-05-01)

Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates
by: Wedad M. Abdelraheem, et al.
Published: (2021-08-01)

In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals
by: Adriana O. Reis, et al.

Impairment of the Cell Wall Ligase, LytR-CpsA-Psr Protein (LcpC), in Methicillin Resistant Staphylococcus aureus Reduces Its Resistance to Antibiotics and Infection in a Mouse Model of Sepsis
by: Fan Li, et al.
Published: (2020-04-01)

Using genomics to explore the epidemiology of vancomycin resistance in a sewage system
by: Emilie Egholm Bruun Jensen, et al.
Published: (2025-01-01)

The Impact of Serum Vancomycin Levels and Minimum Inhibitory Concentrations of Methicillin-Resistant Staphylococcus aureus on Mortality in Patients with Nosocomial Pneumonia
by: Denise Pires Machado, et al.
Published: (2013-01-01)

COMPARATIVE IN- VITRO EVALUATION OF VANCOMYCIN MINIMUM INHIBITORY CONCENTRATIONBY AGAR DILUTION AND E-STRIP IN METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
by: Sheroze Ilyas, et al.
Published: (2021-02-01)

In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
by: Siheng Wang, et al.
Published: (2021-08-01)

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
by: Patel DA, et al.
Published: (2014-10-01)

Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017
by: Lin Huang, et al.
Published: (2019-05-01)

Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study
by: Oguz Resat Sipahi, et al.
Published: (2023-09-01)